Simeprevir and (Especially) Sofosbuvir are Great Leaps Forward — and They Will Cost Plenty

HCV cure just got a whole lot easier with the approval of sofosbuvir. What is the best way to treat HCV genotype 1 today? Take the poll in HIV and ID Observations.

The approval of two new drugs — simeprevir in November and sofosbuvir this past Friday — show great promise for treating hepatitis C virus infection. Both are one pill a day and have fewer side effects than any existing HCV drug, and sofosbuvir adds the benefit of having almost zero important drug-drug interactions. The main problem with these new treatments, says Dr. Paul Sax, is, frankly, their cost. What is the best treatment regimen for HCV genotype 1 today? Take the poll in the HIV and ID Observations blog.

Simeprevir and (Especially) Sofosbuvir are Great Leaps Forward — and They Will Cost Plenty

Topics